News

Nearly all newborns who contract human papillomavirus in the perinatal stage will eliminate the virus in the first six months ...
The Food and Drug Administration just approved an at home test that could be an optional alternative to a yearly pap smear.
Q1 2025 Management View CEO Frank Bedu-Addo highlighted the initiation of the VERSATILE 003 Phase 3 clinical trial of Versamune HPV plus pembrolizumab for first-line recurrence and/or metastatic HPV16 ...
The U.S. Food and Drug Administration approved the Teal Wand as the first alternative to in-office Pap smears, which many ...
Some medical authorities shifted to recommend HPV testing as the primary screening ... Laurel Golio for The New York Times If the test is positive, the patient will be referred to an in-person ...
Women who test positive for HPV will be referred for a traditional Pap smear. Those who do not test positive are not considered at risk of cervical cancer and will not need to screen again for ...
only 3% to 4% of the patients of this study being HPV-positive." Mamtani followed up on the upcoming ASCO poster and durability data. Dr. Bedu-Addo said, "At our last presentation at ESMO ...